Intranasal Dexmedetomidine on Blood Pressure in Elderly Hypertensive Patients Undergoing Cataract Surgery

A phase 3 trial registered on ClinicalTrials.gov. The registry status is recruiting. It plans to enroll 126 participants.

Also called NCT07080229

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; quadruple masking; primary purpose prevention
Phase
Phase 3
Enrolled
  • 126 participants (planned count) (from the registry)
Sponsor
Suez Canal University (from the registry)
Registry
  • NCT NCT07080229
Started
(actual) (from the registry)
Primary completion
(anticipated) (from the registry)
Completion
(anticipated) (from the registry)
Countries
Egypt (from the registry)
Registry status
  • Recruiting (from the registry)

Technical summary

Registry record NCT07080229. Randomized; quadruple masking; primary purpose prevention. Start 2025-07-16 (actual); primary completion 2026-04 (anticipated). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Intranasal Dexmedetomidine on Blood Pressure in Elderly Hypertensive Patients Undergoing Cataract Surgery
Condition
Cataract
Condition
Hypertension
Intervention (Drug)
Intranasal dexmedetomidine
Intervention (Drug)
Intranasal normal saline
Lead sponsor
Suez Canal University (class: other)

Record details

Record id
cardio:ct-nct07080229
Content hash
6145abb2eb22a12bc1f68a1b5b822c6afc133d96c9fa0fe0cc5ec24e2117a51b